211 related articles for article (PubMed ID: 29543791)
21. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
22. Responding to a cVDPV1 outbreak in Ukraine: Implications, challenges and opportunities.
Khetsuriani N; Perehinets I; Nitzan D; Popovic D; Moran T; Allahverdiyeva V; Huseynov S; Gavrilin E; Slobodianyk L; Izhyk O; Sukhodolska A; Hegazi S; Bulavinova K; Platov S; O'Connor P
Vaccine; 2017 Aug; 35(36):4769-4776. PubMed ID: 28528761
[TBL] [Abstract][Full Text] [Related]
23. Improved acute flaccid paralysis surveillance performance in the Democratic Republic of the Congo, 2010-2012.
Alleman MM; Meyer SA; Mulumba A; Nyembwe M; Riziki Y; Mbule A; Mayenga M; Coulibaly T
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S50-61. PubMed ID: 25316874
[TBL] [Abstract][Full Text] [Related]
24. Environmental Isolation of Circulating Vaccine-Derived Poliovirus After Interruption of Wild Poliovirus Transmission - Nigeria, 2016.
Etsano A; Damisa E; Shuaib F; Nganda GW; Enemaku O; Usman S; Adeniji A; Jorba J; Iber J; Ohuabunwo C; Nnadi C; Wiesen E
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):770-3. PubMed ID: 27490081
[TBL] [Abstract][Full Text] [Related]
25. Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 - Worldwide, 2016-2017.
Diop OM; Asghar H; Gavrilin E; Moeletsi NG; Benito GR; Paladin F; Pattamadilok S; Zhang Y; Goel A; Quddus A
MMWR Morb Mortal Wkly Rep; 2017 May; 66(20):538-542. PubMed ID: 28542124
[TBL] [Abstract][Full Text] [Related]
26. A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.
EstÃvariz CF; Watkins MA; Handoko D; Rusipah R; Deshpande J; Rana BJ; Irawan E; Widhiastuti D; Pallansch MA; Thapa A; Imari S
J Infect Dis; 2008 Feb; 197(3):347-54. PubMed ID: 18199031
[TBL] [Abstract][Full Text] [Related]
27. Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo.
Banza Mpiongo P; Kibanza J; Kambol Yav F; Nyombo D; Mwepu L; Basame D; Mpoyi R; Madika C; Hatton T; Mafuta E; Gascon O; Tschirhart K; Nkosi F; Lusamba P; Merritt S; Mwenda J; Tangney S; Hoff NA; Nkamba Mukadi D; Rimoin AW; Kaba D; El Mourid A; Senouci K; Ngoie Mwamba G; Mukamba Musenga E; Cikomola A
Vaccine; 2023 Dec; 41(51):7598-7607. PubMed ID: 37989612
[TBL] [Abstract][Full Text] [Related]
28. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
[TBL] [Abstract][Full Text] [Related]
29. Update on vaccine-derived polioviruses--worldwide, January 2006-August 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(38):996-1001. PubMed ID: 17898693
[TBL] [Abstract][Full Text] [Related]
30. Vaccine-derived polioviruses outbreaks and events in 3 provinces of Democratic Republic of the Congo, 2017.
Wkly Epidemiol Rec; 2018 Mar; 93(11):117-25. PubMed ID: 29546749
[No Abstract] [Full Text] [Related]
31. Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.
Pons-Salort M; Burns CC; Lyons H; Blake IM; Jafari H; Oberste MS; Kew OM; Grassly NC
PLoS Pathog; 2016 Jul; 12(7):e1005728. PubMed ID: 27384947
[TBL] [Abstract][Full Text] [Related]
32. The risk of type 2 oral polio vaccine use in post-cessation outbreak response.
McCarthy KA; Chabot-Couture G; Famulare M; Lyons HM; Mercer LD
BMC Med; 2017 Oct; 15(1):175. PubMed ID: 28974220
[TBL] [Abstract][Full Text] [Related]
33. Circulating vaccine-derived polioviruses: current state of knowledge.
Kew OM; Wright PF; Agol VI; Delpeyroux F; Shimizu H; Nathanson N; Pallansch MA
Bull World Health Organ; 2004 Jan; 82(1):16-23. PubMed ID: 15106296
[TBL] [Abstract][Full Text] [Related]
34. Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011.
Gumede N; Jorba J; Deshpande J; Pallansch M; Yogolelo R; Muyembe-Tamfum JJ; Kew O; Venter M; Burns CC
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S361-7. PubMed ID: 25316856
[TBL] [Abstract][Full Text] [Related]
35. Vaccine-derived polioviruses and the endgame strategy for global polio eradication.
Kew OM; Sutter RW; de Gourville EM; Dowdle WR; Pallansch MA
Annu Rev Microbiol; 2005; 59():587-635. PubMed ID: 16153180
[TBL] [Abstract][Full Text] [Related]
36. Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020.
Darwar R; Biya O; Greene SA; Jorba J; Al Safadi M; Franka R; Wiesen E; Durry E; Pallansch MA
Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A25-A34. PubMed ID: 36863925
[TBL] [Abstract][Full Text] [Related]
37. Update on Vaccine-Derived Polioviruses - Worldwide, January 2015-May 2016.
Jorba J; Diop OM; Iber J; Sutter RW; Wassilak SG; Burns CC
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):763-9. PubMed ID: 27491079
[TBL] [Abstract][Full Text] [Related]
38. Progress toward poliomyelitis eradication--Angola and the Democratic Republic of Congo, January 2002-June 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(34):816-9. PubMed ID: 12944879
[TBL] [Abstract][Full Text] [Related]
39. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.
Burns CC; Shaw J; Jorba J; Bukbuk D; Adu F; Gumede N; Pate MA; Abanida EA; Gasasira A; Iber J; Chen Q; Vincent A; Chenoweth P; Henderson E; Wannemuehler K; Naeem A; Umami RN; Nishimura Y; Shimizu H; Baba M; Adeniji A; Williams AJ; Kilpatrick DR; Oberste MS; Wassilak SG; Tomori O; Pallansch MA; Kew O
J Virol; 2013 May; 87(9):4907-22. PubMed ID: 23408630
[TBL] [Abstract][Full Text] [Related]
40. Progress toward interruption of wild poliovirus transmission--worldwide, January 2010-March 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):582-6. PubMed ID: 21566559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
